214 related articles for article (PubMed ID: 15931812)
1. Computed tomographic volumetric analysis as a predictor of local control in laryngeal cancers treated with conventional radiotherapy.
Hamilton S; Venkatesan V; Matthews TW; Lewis C; Assis L
J Otolaryngol; 2004 Oct; 33(5):289-94. PubMed ID: 15931812
[TBL] [Abstract][Full Text] [Related]
2. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma.
Lo SM; Venkatesan V; Matthews TW; Rogers J
J Otolaryngol; 1998 Oct; 27(5):247-51. PubMed ID: 9800621
[TBL] [Abstract][Full Text] [Related]
3. Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography-determined tumour parameters.
Hermans R; Van den Bogaert W; Rijnders A; Doornaert P; Baert AL
Radiother Oncol; 1999 Jan; 50(1):39-46. PubMed ID: 10225556
[TBL] [Abstract][Full Text] [Related]
4. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone?
Lee WR; Mancuso AA; Saleh EM; Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):683-7. PubMed ID: 8454487
[TBL] [Abstract][Full Text] [Related]
5. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy?
Pameijer FA; Mancuso AA; Mendenhall WM; Parsons JT; Kubilis PS
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1011-21. PubMed ID: 9169807
[TBL] [Abstract][Full Text] [Related]
6. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
[TBL] [Abstract][Full Text] [Related]
7. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
8. Can pretreatment CT predict local control of T2 glottic carcinomas treated with radiation therapy alone?
Mukherji SK; Mancuso AA; Mendenhall W; Kotzur IM; Kubilis P
AJNR Am J Neuroradiol; 1995 Apr; 16(4):655-62. PubMed ID: 7611018
[TBL] [Abstract][Full Text] [Related]
9. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma.
Mancuso AA; Mukherji SK; Schmalfuss I; Mendenhall W; Parsons J; Pameijer F; Hermans R; Kubilis P
J Clin Oncol; 1999 Feb; 17(2):631-7. PubMed ID: 10080608
[TBL] [Abstract][Full Text] [Related]
10. Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes.
Warner L; Lee K; Homer JJ
Clin Otolaryngol; 2017 Jun; 42(3):629-636. PubMed ID: 27863075
[TBL] [Abstract][Full Text] [Related]
11. [The effect of primary tumor localization on radiotherapy for supraglottic and glottic cancer].
Goleń M; Trybalska G; Namysłowski G
Otolaryngol Pol; 1998; 52(1):45-51. PubMed ID: 9591421
[TBL] [Abstract][Full Text] [Related]
12. Factors leading to the use of alternate treatment modalities following transoral laser excision of T1 and T2 glottic squamous cell carcinoma.
Pham TA; De Freitas R; Sigston E; Vallance N
ANZ J Surg; 2012 Oct; 82(10):720-3. PubMed ID: 22901105
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.
Chung SY; Kim KH; Keum KC; Koh YW; Kim SH; Choi EC; Lee CG
Cancer Res Treat; 2018 Jan; 50(1):156-163. PubMed ID: 28301924
[TBL] [Abstract][Full Text] [Related]
15. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
Fein DA; Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery.
Mendenhall WM; Parsons JT; Mancuso AA; Stringer SP; Cassisi NJ
Head Neck; 1996; 18(1):24-35. PubMed ID: 8774919
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for management of t1-t2 glottic cancer at a private practice.
Jones DA; Mendenhall CM; Kirwan J; Morris CG; Donnan A; Holwerda S; Kraus ST; Mann CJ; Grant JR; Donnan B; Mendenhall WM
Am J Clin Oncol; 2010 Dec; 33(6):587-90. PubMed ID: 20051812
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer.
Rutkowski T; Wygoda A; Składowski K; Hejduk B; Rutkowski R; Kołosza Z; Maciejewski B
Strahlenther Onkol; 2013 Oct; 189(10):861-6. PubMed ID: 23982169
[TBL] [Abstract][Full Text] [Related]
19. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
[TBL] [Abstract][Full Text] [Related]
20. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
